Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Dermatology

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.139.7.857PMID 12873880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

  2002cited by this paper
• Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides.

  2001cited by this paper
• Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.

  2001cited by this paper
• Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.

  2000cited by this paper
• Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides.

  2000cited by this paper
• Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.

  2000cited by this paper
• Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.

  1999cited by this paper
• Prognostic factor analysis in mycosis fungoides/Sézary syndrome.

  1999cited by this paper
• The changing survival of patients with mycosis fungoides

  1999cited by this paper
• Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept.

  1999cited by this paper
• Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.

  1999cited by this paper
• The changing survival of patients with mycosis fungoides

  1999cited by this paper
• Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.

  1998cited by this paper
• Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.

  1998cited by this paper
• Role of histology in providing prognostic information in mycosis fungoides

  1998cited by this paper
• Mycosis fungoides in young patients: clinical characteristics and outcome.

  1998cited by this paper
• Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.

  1996cited by this paper
• Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.

  1996cited by this paper
• Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.

  1995cited by this paper
• CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides.

  1995cited by this paper
• Lymph node classification systems in cutaneous T‐cell lymphoma. Evidence for the utility of the working formulation of non‐Hodgkin's lymphomas for clinical usage

  1994cited by this paper
• Prognostic clinicopathologic factors in cutaneous T-cell lymphoma.

  1991cited by this paper
• Marrow involvement in cutaneous T-cell lymphoma. A clinicopathologic study of 60 cases.

  1989cited by this paper
• Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.

  1988cited by this paper
• Clinical staging for cutaneous T-cell lymphoma.

  1984cited by this paper
• Prognostic variables in mycosis fungoides

  1981cited by this paper
• Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

  1979cited by this paper
• Mycosis fungoides.

  1972cited by this paper
• The analysis of binary data

  1971cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• synDNA vaccine against TCR chains and neoantigens for T cell lymphoma therapy

  2026cites this paper
• Mycosis Fungoides in Skin Nodule

  2026cites this paper
• Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab

  2025cites this paper
• Overall and Cause‐Specific Mortality Among Patients With Cutaneous T‐Cell Lymphoma in the United States

  2025cites this paper
• The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma

  2025cites this paper
• Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome

  2025cites this paper
• Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024.

  2025cites this paper
• The Clinicopathologic Spectrum of Primary Cutaneous Lymphomas - A Single Centre Experience

  2025cites this paper
• Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides

  2025cites this paper
• Central Nervous System Manifestations of Cutaneous Lymphomas

  2025influential citation
• Modified recommendations for the radiation dose in patients with mycosis fungoides and localised lesional disease based on a retrospective analysis of treatment outcomes.

  2025cites this paper
• Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?

  2025cites this paper
• Large cell transformation outweighs CD30 expression as a prognostic factor in Taiwanese patients with mycosis fungoides: A retrospective study from a referral center in Southern Taiwan

  2025cites this paper
• A comprehensive update of extracutaneous involvement of mycosis fungoides: A narrative review of literature

  2025cites this paper
• Atypical Lesion on the Lower Lip

  2025cites this paper
• Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management

  2025cites this paper
• Large‐cell transformation of mycosis fungoides: Patterns of care and patient outcomes

  2025cites this paper
• Spatial transcriptomics of progression gene signature and tumor microenvironment leading to progression in mycosis fungoides

  2025cites this paper
• Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

  2025cites this paper
• From dimensions through dynamics to outcomes – lymph nodes and skin assessments predict CTCL outcomes

  2025cites this paper
• Diagnose der Mycosis fungoides im Frühstadium: Ansichten von Experten und Nicht‐Experten für kutane Lymphome

  2025cites this paper
• Japanese Dermatological Association Guidelines: Outlines of Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2025

  2025cites this paper
• Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma

  2025influential citation
• An evaluation of denileukin diftitox for the treatment of relapsed or refractory cutaneous T-cell lymphoma

  2025cites this paper
• Systemic immune‐inflammation index and pan‐immune value as prognostic indicators of clinical outcomes in mycosis fungoides: A retrospective cohort study

  2025cites this paper
• ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

  2025cites this paper
• Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon

  2024cites this paper
• CD4/CD8 double-negative mycosis fungoides: a review

  2024cites this paper
• Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation.

  2024cites this paper
• Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides

  2024cites this paper
• Evaluation of the prognostic significance of clinical features of tumoral lesions in an extensive series of mycosis fungoides

  2024cites this paper
• Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides

  2024cites this paper
• The Prognostic Value of Histopathological Features in Early-Stage Mycosis Fungoides: Insights from a Retrospective–Prospective Cohort Study

  2024cites this paper
• Comparison of 2 T-Cell Receptor-γ Clonality Assays on Skin Biopsies Suspicious for Mycosis Fungoides

  2024cites this paper
• The Impact of Primary Tumor Site on Survival in Mycosis Fungoides.

  2024cites this paper
• A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States

  2024cites this paper
• The Impact of Regularly Used Treatments on Daily Life of Cutaneous T‐Cell and B‐Cell Lymphoma Patients

  2024cites this paper
• Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences

  2024cites this paper
• RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides

  2024cites this paper
• A rapidly growing breast tumour in a young woman

  2024cites this paper
• On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome.

  2024cites this paper
• Multi-Omic Data Integration Suggests Putative Microbial Drivers of Aetiopathogenesis in Mycosis Fungoides

  2024cites this paper
• Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.

  2024cites this paper
• Pediatric Mycosis Fungoides Mimicking Benign Dermatoses: A Report of a Rare Case

  2024cites this paper
• Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

  2024cites this paper
• ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.

  2024cites this paper
• Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma

  2024cites this paper
• Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.

  2024cites this paper
• Romidepsin and afatinib abrogate JAK-STAT signaling and elicit synergistic antitumor effects in cutaneous T-cell lymphoma.

  2024cites this paper
• Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies

  2024cites this paper
• A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome

  2024cites this paper
• Cutaneous T-cell Lymphoma.

  2024cites this paper
• Dermatoscopic Characteristics, Lesional Capillaroscopic Features, and Histopathological Correlation of Small Plaque Parapsoriasis and Mycosis Fungoides

  2024cites this paper
• Pustular mycosis fungoides has a poor outcome: a multicentric clinico-pathological and molecular case series study.

  2024cites this paper
• Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify Sézary syndrome patients with low blood burden.

  2024cites this paper
• Clinically assessed mycosis fungoides tumor burden index as a prognostic marker in tumor-stage mycosis fungoides: a retrospective cohort study

  2024cites this paper
• Radiation therapy for the management of T cell cutaneous lymphomas. Updated results of the role of low dose total skin electron beam (TSEB) therapy

  2024cites this paper
• New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications

  2023cites this paper
• Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review

  2023cites this paper
• Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy.

  2023cites this paper
• Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management

  2023cites this paper
• Total Skin Treatment with Helical Arc Radiotherapy

  2023cites this paper
• Characteristics associated with quality of life in the early stages of Mycosis Fungoides

  2023cites this paper
• Cutaneous lymphomas—fast facts about an orphan disease—a short review

  2023cites this paper
• Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review

  2023cites this paper
• Harnessing the immune system in the treatment of cutaneous T cell lymphomas

  2023cites this paper
• Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.

  2023cites this paper
• Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study

  2023cites this paper
• Immunosequencing applications in cutaneous T-cell lymphoma

  2023cites this paper
• China Anti-Cancer Association (CACA) guidelines for holistic integrative management of lymphoma (version 2022)

  2023cites this paper
• Mycosis fungoides palmaris and plantaris.

  2023cites this paper
• Epidemiologie reifzelliger T‐ und NK‐Zell‐Lymphome in Deutschland – Eine repräsentative Querschnittanalyse von GKV‐Routinedaten

  2023cites this paper
• Epidemiology of mature T/NK‐cell lymphomas in Germany – A representative cross‐sectional study based on SHI claims data

  2023cites this paper
• Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis

  2023cites this paper
• Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec.

  2023cites this paper
• Первинні Т-клітинні лімфоми шкіри: класифікація, діагностика, лікування (огляд літератури)

  2023cites this paper
• Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T‐cell lymphoma

  2023cites this paper
• Clinicopathologic characteristics and outcomes of patients with mycosis fungoides: A single tertiary center retrospective analysis in Saudi Arabia.

  2023cites this paper
• Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.

  2023cites this paper
• Causes of Death in Cutaneous T-Cell Lymphoma Patients

  2023cites this paper
• Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.

  2023cites this paper
• Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor

  2023cites this paper
• Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care

  2023influential citation
• Oral Mycosis Fungoides: Report of 2 Cases and Review of the Literature

  2023cites this paper
• Psoriasiform mycosis fungoides: A clinical and prognostic retrospective cohort study.

  2023cites this paper
• Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature

  2023influential citation
• YKL‐40 immunoexpression as a prognosticator of mycosis fungoides

  2023cites this paper
• Mycosis fungoides and Sézary syndrome

  2023cites this paper
• Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.

  2023cites this paper
• Cost–utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma

  2023cites this paper
• Micosis fungoide presentación agresiva, reporte de caso

  2023cites this paper
• Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

  2022cites this paper
• Ocular adnexal lymphoma: Subtype‐specific clinical and genetic features

  2022cites this paper
• Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients

  2022cites this paper
• Illness Perception Regarding Early-stage Mycosis Fungoides among Dermatologists: A Multi-centre Cross-sectional Study

  2022cites this paper
• CRP Levels as a Prognostic Factor in Mycosis Fungoides.

  2022cites this paper
• Factors Associated With In-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis

  2022cites this paper
• Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study

  2022cites this paper
• Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome.

  2022cites this paper
• EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related quality of life in patients with mycosis fungoides and Sézary syndrome: Real‐world data in Spanish patients (MICADOS Study)

  2022cites this paper